Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Daratumumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Daratumumabmarket, defines the market attractiveness level of Daratumumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Daratumumab industry, describes the types of Daratumumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Daratumumab market and the development prospects and opportunities of Daratumumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Daratumumab market in Chapter 13.
By Player:
Johnson＆Johnson
By Type:
100mg Injection
400mg Injection
By End-User:
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Daratumumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Daratumumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Daratumumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Daratumumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Daratumumab Market Analysis and Outlook to 2022
-
7.1 Global Daratumumab Consumption (2017-2022)
-
7.2 United States Daratumumab Consumption (2017-2022)
-
7.3 Europe Daratumumab Consumption (2017-2022)
-
7.4 China Daratumumab Consumption (2017-2022)
-
7.5 Japan Daratumumab Consumption (2017-2022)
-
7.6 India Daratumumab Consumption (2017-2022)
-
7.7 South Korea Daratumumab Consumption (2017-2022)
8 Region and Country-wise Daratumumab Market Analysis and Outlook to 2028
-
8.1 Global Daratumumab Consumption Forecast (2022-2028)
-
8.2 United States Daratumumab Consumption Forecast (2022-2028)
-
8.3 Europe Daratumumab Consumption Forecast (2022-2028)
-
8.4 China Daratumumab Consumption Forecast (2022-2028)
-
8.5 Japan Daratumumab Consumption Forecast (2022-2028)
-
8.6 India Daratumumab Consumption Forecast (2022-2028)
-
8.7 South Korea Daratumumab Consumption Forecast (2022-2028)
9 Global Daratumumab Market Outlook by Types and Applications to 2022
-
9.1 Global Daratumumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100mg Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 400mg Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Daratumumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diffuse Large B Cell Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Follicular Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Mantle Cell Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Global Daratumumab Market Outlook by Types and Applications to 2028
-
10.1 Global Daratumumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 100mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 400mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Daratumumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diffuse Large B Cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Follicular Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Mantle Cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Daratumumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Daratumumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Daratumumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Daratumumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Daratumumab Market Competitive Analysis
-
14.1 Johnson＆Johnson
-
14.1.1 Johnson＆Johnson Company Details
-
14.1.2 Johnson＆Johnson Daratumumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson＆Johnson Daratumumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Daratumumab
-
Figure Daratumumab Picture
-
Table Global Daratumumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Daratumumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Daratumumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Daratumumab Consumption by Country (2017-2022)
-
Figure United States Daratumumab Consumption and Growth Rate (2017-2022)
-
Table Europe Daratumumab Consumption and Growth Rate (2017-2022)
-
Figure China Daratumumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Daratumumab Consumption and Growth Rate (2017-2022)
-
Figure India Daratumumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Daratumumab Consumption and Growth Rate (2017-2022)
-
Figure Global Daratumumab Consumption Forecast by Country (2022-2028)
-
Figure United States Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Daratumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg Injection Consumption and Growth Rate (2017-2022)
-
Figure Global 400mg Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure Global Diffuse Large B Cell Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Follicular Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Mantle Cell Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 400mg Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diffuse Large B Cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Follicular Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mantle Cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Daratumumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Daratumumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson＆Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson＆Johnson Daratumumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson＆Johnson Daratumumab Product and Service
-
